Gaps in the knowledge of human platelet lysate as a cell culture supplement for cell therapy: a joint publication from the AABB and the International Society for Cell & Gene Therapy

Abstract excerpt

Cell therapeutics are emerging as a viable modality to treat challenging diseases such as cancer, organ degeneration, or (auto)immune diseases resulting in an increased demand for their large-scale, high-quality production. Currently, fetal bovine serum (FBS) is the most widely used growth factor supplement for the expansion of human cell therapy products. However, there has been a strong impetus from regulatory...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Mesenchymal stem cell research
• Share to Periodontal Regeneration and Treatments
• Share to Tissue Engineering and Regenerative Medicine